• OPEN AN ACCOUNT
Indian Indices
Sensex
77,540.83 3.11
( 0.00%)
Global Indices
Nasdaq
53,294.39 514.18
(0.97%)
Dow Jones
7,693.51 31.35
(0.41%)
Hang Seng
65,893.13 -323.66
(-0.49%)
Nikkei 225
10,809.01 60.85
(0.57%)
Forex
USD-INR
95.67 0.05
(0.05%)
EUR-INR
111.76 0.57
(0.51%)
GBP-INR
130.35 0.55
(0.42%)
JPY-INR
0.60 0.00
(0.11%)

EQUITY - MARKET SCREENER

Medicamen Organics Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
92885
INE0PE401018
23.677563
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MEDIORG
0
29.56
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

mstc ltd
Ridhi Synthetics standalone net profit declines 11.76% in the March 2026 quarter
May 28,2026
Net profit of Ridhi Synthetics declined 11.76% to Rs 0.15 crore in the quarter ended March 2026 as against Rs 0.17 crore during the previous quarter ended March 2025. Sales rose 9.09% to Rs 0.12 crore in the quarter ended March 2026 as against Rs 0.11 crore during the previous quarter ended March 2025.

For the full year,net profit declined 25.23% to Rs 0.80 crore in the year ended March 2026 as against Rs 1.07 crore during the previous year ended March 2025. Sales rose 16.28% to Rs 0.50 crore in the year ended March 2026 as against Rs 0.43 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.120.11 9 0.500.43 16
OPM %-33.33-45.45 --28.00-34.88 -
PBDT0.210.23 -9 1.131.48 -24
PBT0.190.22 -14 1.061.43 -26
NP0.150.17 -12 0.801.07 -25